Central theme across all four projects — ComPat, CompBioMed, VECMA, and CompBioMed2 — covering computing patterns, performance prediction, and exascale methods.
CBK SCI CON LIMITED
Scientific computing consultancy specializing in high-performance multiscale simulation for exascale applications and computational biomedicine.
Their core work
CBK Sci Con is a London-based scientific computing consultancy specializing in high-performance and multiscale computing for complex simulations. They provide expertise in designing computing patterns, performance measurement, and verification methods for exascale applications. Their work bridges computational infrastructure with domain-specific applications, particularly in computational biomedicine and precision medicine. They help research consortia build and optimize simulation workflows that run efficiently on supercomputing infrastructure.
What they specialise in
Core participant in both CompBioMed (2016-2019) and CompBioMed2 (2019-2024), the flagship Centre of Excellence in Computational Biomedicine.
Contributed to VECMA (2018-2021), focused on verification and validation methods for exascale multiscale applications.
ComPat project explicitly targeted performance measurement and prediction for multiscale computing patterns.
How they've shifted over time
In their early H2020 period (2015-2018), CBK Sci Con focused on foundational multiscale computing patterns, performance measurement, and building experimental execution environments — essentially the computational infrastructure layer. From 2018 onward, their work shifted toward applying these methods at exascale and in domain-specific contexts, particularly personalised medicine and biomedicine simulation. The continuation from CompBioMed to CompBioMed2 (with significantly increased funding) shows a deepening commitment to computational biomedicine as their primary application domain.
Moving from general HPC methodology toward domain-applied exascale simulation, with computational biomedicine as their anchor application area.
How they like to work
CBK Sci Con operates exclusively as a consortium participant, never as coordinator, which is consistent with a specialist consultancy that brings targeted HPC expertise to larger research initiatives. With 28 unique partners across 11 countries from just 4 projects, they work in large, international consortia — typical of EU Centres of Excellence and flagship computing projects. Their repeat involvement in CompBioMed and CompBioMed2 suggests they are valued enough to be re-invited, indicating reliable delivery and strong working relationships.
Well-connected across 11 countries with 28 unique consortium partners, primarily through large-scale HPC and computational biomedicine networks. Their repeat presence in CompBioMed projects places them within Europe's top computational biomedicine community.
What sets them apart
As a private SME consultancy rather than a university or research institute, CBK Sci Con occupies an unusual niche in the HPC research ecosystem — they bring commercial agility and focused computing expertise to academic-heavy consortia. Their combination of deep multiscale computing methodology with applied biomedicine experience makes them a rare bridge between HPC infrastructure developers and domain scientists. For consortium builders, they offer specialist computing architecture knowledge without the overhead of engaging a large institution.
Highlights from their portfolio
- CompBioMed2Their largest project by far (EUR 763K), a continuation of the Centre of Excellence in Computational Biomedicine running through 2024, signaling sustained trust and growing responsibility.
- VECMAFocused on verification and validation for exascale computing — a critical methodological capability that underpins confidence in large-scale simulation results.
- ComPatTheir earliest H2020 project, establishing foundational work on multiscale computing patterns that informed their later, larger engagements.